Medical Specialty >> Pharmacy
U.S. Opioid Painkiller Abuse May Be Leveling Off
9:00 AM CDT.
Rate plateaus as doctors are urged to recommend nondrug pain treatments
By Amy NortonHealthDay Reporter Read article
- Creepy Creatures Can Be Medical Marvels, Too
- Easy Fix for Post-Op Shivers?
- Hepatitis C Screening May Boost Opioid Treatment Success
- Drug OD Rate Now Higher in Rural U.S. Than Cities: CDC
JOURNAL UPDATE
Limited Evidence of Benefit for Medical Cannabinoids in Children
12:00 PM CDT. Strongest evidence for benefit in chemo-induced nausea, vomiting; other uses need more evidence- Caution for PLEX in Progressive Multifocal Leukoencephalopathy
- Herbal and Dietary Supplements Are Commonly Mislabeled
- H7N9 Avian Influenza May Be Capable of Pandemic
MONTHLY JOURNAL SUMMARY
September 2017 Briefing - Pharmacy
September 30, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
